Martina Nasralla, PharmD Candidate

BV-R2 combination shows survival benefit across high-risk subgroups.

Discover the latest advancements in multiple myeloma treatment, including new therapies and FDA approvals that enhance patient outcomes and survival rates.

Intravenous immunoglobulin (IVIG) is a vital treatment for immunodeficiency and autoimmune disorders, with diverse mechanisms, brand-specific differences, and patient-centered considerations shaping safe and effective use.

Though new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.